echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > It is not clear whether the change of application status of metoxadone tablet, a new drug of shutaishen, has been approved

    It is not clear whether the change of application status of metoxadone tablet, a new drug of shutaishen, has been approved

    • Last Update: 2015-05-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to the information on the website of CFDA on May 4, the processing status of shutaishen new drug methadone tablet was changed to "approved - to be certified", but it was not found that it had on-site inspection records, whether it was approved or not Shutaishen company said that due to the absence of relevant personnel, it is unable to reply for the time being, and will give an answer after verification to relevant personnel Generally speaking, there is a process of on-site inspection before the approval of new drugs As early as 2011, shutaishen had expected that methadone tablets could be listed in the next year In November 2013, Ma Lina, deputy general manager and Secretary of the company, said that the company might be listed in the first half of 2014 to sell troxerox capsules and methadone tablets The registration and application process of the drug not only has a long time span, but also has been suspended Methadone is a kind of central muscle relaxant, which is mainly used as an auxiliary drug for local muscle spasm pain caused by inflammation and trauma It has been listed in the United States for many years, and its efficacy has been determined It has repeatedly ranked in the top 200 prescription drugs in the United States.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.